News Networks
Topics
Stories
People

  • My Networks
  • Popular
  • Recent
  • ABC...XYZ
  • Create New
  • Search
  • Popular
  • Recent
  • Rising Fast
  • ABC...XYZ
  • Popular Today
  • Popular Week
  • Popular Month
  • Rising Fast
  • Hot Discussions
  • My Newsmakers
  • My Followers
  • Recently Active
  • Popular
  • Find
  • Invite Friends
Connect
Sign in using facebook |
Log in |
Sign Up


Hi there. I'm Jason, one of the founders of socialmedian.
socialmedian delivers the news, filtered by your network.
We'd love to have you join in.
You can use facebook connect to sign in.
Connect
OR
Log in 
|
Sign up


Create your socialmedian account
Email
Required

Password
Required

The password must be atleast 6 characters
Username
Required

http://www.socialmedian.com/username
This is same as my twitter ID
Security check

I agree to the terms and conditions and the privacy policy.
Loading...


Already a user? Please Log In
Invalid Login!
Email

Password

Remember me:
Loading...


Forgot Password?

Email:

By
Add News Flash
User-submitted headlines for this story

Loading

1
Clip
Eyelash growth drug
Source: Boing Boing
Dec 30, 2008


Dislike
 
0%
 
0%

Like

Summary
The US Food and Drug Administration (FDA) has approved a new prescription drug, Latisse, for lengthening eyelashes. The active ingredient in the drug was first used to treat glaucoma. Then the manufacturer, Allergan, realized that one of the side effects, eyelash growth, was marketable. From Scientific American:


The med... should be available by March from a doctor or with a prescription from one. Price tag: $120 for a month’s supply. According to manufacturer Allergan, the drug usually nets results two to four months after users start it. Potential side effects: Some 4 percent of users experience eye itching and redness, and it may also temporarily darken the skin of the eyelid, according to the company...



It's not clear exactly why Latisse promotes eyelash growth, but the company speculates that the drug may increase the length and amount of hair that sprouts during the growth cycle. It’s possible that the drug may also spur eyebrow and scalp hair growth, doctors told the Wall Street Journal. But Allergan spokesperson Heather Katt says the company hasn't expl ...Read the full article

Comments (0)
Add Your Comment
Please enter your Email Id to get a new password
Forgot your password?
Email:

Add something

Snip
News
Site

Instantly Clip News From Any Website
Clip it! on s|m
Or, Enter News Directly Here
Headline:

URL:
(Optional)

Description:
(Optional)

Adding a News...


Add Snip
Adding a Snip...


Now you can import your favorite sites to your socialmedian page
Loading...

Loading...


Is this you?
Stats

Mood
0% Like

0% Dislike

1 Clip

Loading...

Outflewtheweb

Share this story

Network
Email
Tweet
Share with the News Network
Email ID's
(multiple Email ID's separated by commas)
Message
Also post this message as a public comment
Don't worry. We won't share the name or email address of the person that you sent the story to.
Loading...

Message
119

bit.ly (short) url will be added to the message.
Link to discuss this story on socialmedian

Link to the original story

Twitter ID

Password

Save my twitter password
Tweet will be sent using   (change)
Topics

American
food
New
users
Add Topics

Comma Separated.
Belongs to News Networks

Tech News Matters (Users: 54)
Stories in 24 hours: 421
American Foreign Relations Network (Users: 6)
Stories in 24 hours: 305
The Joanikin Network (Users: 1)
Stories in 24 hours: 501
General New Media aggregation (Users: 3)
Stories in 24 hours: 11
Restaurant Reviews (Users: 8)
Stories in 24 hours: 14
The Social Media News Network (Users: 1)
Stories in 24 hours: 1056
Show more
Show less
Register using your Twitter ID and we'll help you easily connect
your accounts and find people you already know.

We constantly make updates and enhancements based on user feedback. Follow socialmedian on Twitter
Help us out and report a bug or suggest a new feature! Check out our blog for regular company updates, notables, and to see what we're currently working on.
Report a Bug
Suggest a Feature


 Sending...
close
socialmedian Inc. 2008 - 2009
About socialmedian    |        |    Terms of Service    |    Privacy Policy